Alvotech (NAS:ALVO)
$ 12.13 -0.05 (-0.41%) Market Cap: 3.67 Bil Enterprise Value: 4.87 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 9/100

Alvotech SA at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 04:15PM GMT
Release Date Price: $8.88 (-5.13%)
Thibault Boutherin
Morgan Stanley, Research Division - Equity Analyst

So thanks, everyone, for joining this session of the Morgan Stanley Global Healthcare Conference. My name is Thibault Boutherin. I'm part of the pharma equity research team based in London.

Before we start, I need to refer to important disclosures. Please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representatives. So for this session, I am delighted to have with me Ming Li, Chief Strategy Officer at Alvotech. So thank you very much for joining us today. I will kick off the Q&A and if you also want to ask any questions, please do.

Questions & Answers

Thibault Boutherin
Morgan Stanley, Research Division - Equity Analyst

But before we start, Ming Li, maybe you would start with, for investors who are less familiar, presentation of the business and maybe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot